Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
McKinsey
Queensland Health
Baxter
UBS
Cerilliant
Argus Health
Mallinckrodt
Farmers Insurance

Generated: February 25, 2018

DrugPatentWatch Database Preview

Akorn Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AKORN INC, and what generic and branded alternatives to AKORN INC drugs are available?

AKORN INC has thirty-three approved drugs.

There are three tentative approvals on AKORN INC drugs.

Summary for Akorn Inc
US Patents:0
Tradenames:30
Ingredients:30
NDAs:33

Drugs and US Patents for Akorn Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 090163-001 Jun 24, 2009 AP RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride INJECTABLE;INJECTION 075086-001 Apr 9, 1998 AP RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065305-004 Jan 11, 2008 AP RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc LABETALOL HYDROCHLORIDE labetalol hydrochloride INJECTABLE;INJECTION 075524-001 Nov 29, 1999 AP RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 203058-001 Sep 22, 2014 AT RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065305-003 Jan 11, 2008 AP RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc ACETYLCYSTEINE acetylcysteine INJECTABLE;INTRAVENOUS 203173-001 Mar 24, 2015 AP RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 204532-001 Jan 10, 2017 AT RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 202795-001 Jan 24, 2013 OTC No No ➤ Sign Up ➤ Sign Up
Akorn Inc CYCLOPENTOLATE HYDROCHLORIDE cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 205937-001 Dec 9, 2015 AT RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Healthtrust
Deloitte
Teva
Queensland Health
Merck
Fuji
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot